Research graph
References from Total flavonoids of Desmodium styracifolium attenuate nephrolithiasis via reducing calcium oxalate crystallization and renal inflammation. Local targets link to admitted publications; unresolved targets remain external evidence.
Urolithiasis unveiled: pathophysiology, stone dynamics, types, and inhibitory mechanisms: a review
10.1186/s12301-024-00436-z · 2024 · External reference
Kidney stone disease: risk factors, pathophysiology and management
10.1038/s41581-025-00990-x · 2025 · External reference
Trends in kidney stone prevalence among U.S. adults: a concerning contemporary gender analysis from the NHANES database
10.5489/cuaj.8935 · 2024 · External reference
Mitochondrial Enzyme HIBADH protects against calcium oxalate nephrolithiasis by modulating oxidative stress and apoptosis
10.1016/j.abb.2025.110452 · 2025 · External reference
Schaftoside suppresses pentylenetetrazol-induced seizures in zebrafish via suppressing apoptosis, modulating inflammation, and oxidative stress
10.1021/acschemneuro.1c00314 · 2021 · External reference
Unveiling the antiurolithiatic potentiality of two benzene sulfonamide derivatives against ethylene glycol-induced renal calculi
10.1016/j.nefroe.2025.02.003 · 2025 · External reference
Physiopathology and etiology of stone formation in the kidney and the urinary tract
10.1007/s00467-009-1116-y · 2010 · External reference
In focus: perplexing increase of urinary stone disease in children, adolescent and young adult women and its economic impact
10.3389/fmed.2023.1272900 · 2023 · External reference
Principles and standards for reporting animal experiments in the journal of physiology and experimental physiology
10.1113/ep085299 · 2015 · External reference
Effect of Desmodium styracifolium‐triterpenoid on calcium oxalate renal stones
10.1111/j.1464-410x.1993.tb15906.x · 1993 · External reference
A rat model of acute kidney injury through systemic hypoperfusion evaluated by micro-US, color and PW-Doppler
10.1007/s11547-018-0962-8 · 2019 · External reference
Prolyl hydroxylase domain inhibitors prevent kidney crystal formation by suppressing inflammation
10.1007/s00240-024-01677-x · 2024 · External reference
Dual modulatory effects of diosmin on calcium oxalate kidney stone formation processes: crystallization, growth, aggregation, crystal-cell adhesion, internalization into renal tubular cells, and invasion through extracellular matrix
10.1016/j.biopha.2021.111903 · 2021 · External reference
Study on the constituents of Desmodium styracifolium
10.1248/cpb.37.2229 · 1989 · External reference
Activation of Farnesoid X receptor by schaftoside ameliorates acetaminophen-induced hepatotoxicity by modulating oxidative stress and inflammation
10.1089/ars.2019.7791 · 2020 · External reference
Schaftoside reduces inflammation in Aspergillus fumigatus keratitis through the inhibition of the TLR4/MyD88 pathway
10.1016/j.cyto.2023.156483 · 2024 · External reference
The genus Desmodium (Fabaceae)-traditional uses in Chinese medicine, phytochemistry and pharmacology
10.1016/j.jep.2011.09.053 · 2011 · External reference
Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats
10.1007/s00240-011-0401-y · 2012 · External reference
Desmodium styracifolium: botanical and ethnopharmacological insights, phytochemical investigations, and prospects in pharmacology and pharmacotherapy
10.1016/j.heliyon.2024.e25058 · 2024 · External reference
Kidney stones: a global picture of prevalence, incidence, and associated risk factors
10.3909/riu0459 · 2010 · External reference
A comparative study of kidney lithogenic agents in Wistar rats by invasive and noninvasive methods
10.1016/j.vascn.2025.107743 · 2025 · External reference
NIH Image to ImageJ: 25 years of image analysis
10.1038/nmeth.2089 · 2012 · External reference
Styracifoline from the Vietnamese plant Desmodium styracifolium: a potential inhibitor of diabetes-related and thrombosis-based proteins
10.1021/acsomega.1c02840 · 2021 · External reference
Pediatric urinary stone disease in the United States: the urologic diseases in America project
10.1016/j.urology.2019.04.012 · 2019 · External reference
Antilithic effects of extracts from different polarity fractions of Desmodium styracifolium on experimentally induced urolithiasis in rats
10.1007/s00240-015-0795-z · 2015 · External reference
Total flavone of Desmodium styracifolium relieved apoptosis and autophagy of COM-induced HK-2 cells by regulating KIM-1 via p38/MAPK pathway
10.1007/s11010-017-3201-z · 2018 · External reference
Puerarin alleviates apoptosis and inflammation in kidney stone cells via the PI3K/AKT pathway: network pharmacology and experimental verification
10.1111/jcmm.70180 · 2024 · External reference
Bioactive compound schaftoside from Clinacanthus nutans attenuates acute liver injury by inhibiting ferroptosis through activation the Nrf2/GPX4 pathway
10.1016/j.jep.2024.118135 · 2024 · External reference
Total favonoids of Desmodium Styracifolium relieve renal ischemia–reperfusion injury by suppressing ferroptosis through P53/SLC7A11/GPX4 signaling pathway: (Running title) TFDS relieved renal ischemia–reperfusion injury
10.1007/s10863-025-10076-9 · 2025 · External reference
Schaftoside improves cerebral ischemia-reperfusion injury by enhancing autophagy and reducing apoptosis and inflammation through the AMPK/mTOR pathway
10.17219/acem/152207 · 2022 · External reference
Isoflavanones and their O-glycosides from Desmodium styracifolium
10.1016/j.phytochem.2007.02.015 · 2007 · External reference
Total flavonoids of Desmodium styracifolium attenuates the formation of hydroxy-l-proline-induced calcium oxalate urolithiasis in rats
10.1007/s00240-017-0985-y · 2018 · External reference
Schaftoside ameliorates oxygen glucose deprivation-induced inflammation associated with the TLR4/Myd88/Drp1-related mitochondrial fission in BV2 microglia cells
10.1016/j.jphs.2018.10.012 · 2019 · External reference
Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats
10.1007/s00240-011-0401-y · ExternalCitation · doi-reference
Antilithic effects of extracts from different polarity fractions of Desmodium styracifolium on experimentally induced urolithiasis in rats
10.1007/s00240-015-0795-z · ExternalCitation · doi-reference
Total flavonoids of Desmodium styracifolium attenuates the formation of hydroxy-l-proline-induced calcium oxalate urolithiasis in rats
10.1007/s00240-017-0985-y · ExternalCitation · doi-reference
Prolyl hydroxylase domain inhibitors prevent kidney crystal formation by suppressing inflammation
10.1007/s00240-024-01677-x · ExternalCitation · doi-reference
Physiopathology and etiology of stone formation in the kidney and the urinary tract
10.1007/s00467-009-1116-y · ExternalCitation · doi-reference
Total favonoids of Desmodium Styracifolium relieve renal ischemia–reperfusion injury by suppressing ferroptosis through P53/SLC7A11/GPX4 signaling pathway: (Running title) TFDS relieved renal ischemia–reperfusion injury
10.1007/s10863-025-10076-9 · ExternalCitation · doi-reference
Total flavone of Desmodium styracifolium relieved apoptosis and autophagy of COM-induced HK-2 cells by regulating KIM-1 via p38/MAPK pathway
10.1007/s11010-017-3201-z · ExternalCitation · doi-reference
A rat model of acute kidney injury through systemic hypoperfusion evaluated by micro-US, color and PW-Doppler
10.1007/s11547-018-0962-8 · ExternalCitation · doi-reference
Mitochondrial Enzyme HIBADH protects against calcium oxalate nephrolithiasis by modulating oxidative stress and apoptosis
10.1016/j.abb.2025.110452 · ExternalCitation · doi-reference
Dual modulatory effects of diosmin on calcium oxalate kidney stone formation processes: crystallization, growth, aggregation, crystal-cell adhesion, internalization into renal tubular cells, and invasion through extracellular matrix
10.1016/j.biopha.2021.111903 · ExternalCitation · doi-reference
Schaftoside reduces inflammation in Aspergillus fumigatus keratitis through the inhibition of the TLR4/MyD88 pathway
10.1016/j.cyto.2023.156483 · ExternalCitation · doi-reference
Desmodium styracifolium: botanical and ethnopharmacological insights, phytochemical investigations, and prospects in pharmacology and pharmacotherapy
10.1016/j.heliyon.2024.e25058 · ExternalCitation · doi-reference
The genus Desmodium (Fabaceae)-traditional uses in Chinese medicine, phytochemistry and pharmacology
10.1016/j.jep.2011.09.053 · ExternalCitation · doi-reference
Bioactive compound schaftoside from Clinacanthus nutans attenuates acute liver injury by inhibiting ferroptosis through activation the Nrf2/GPX4 pathway
10.1016/j.jep.2024.118135 · ExternalCitation · doi-reference
Schaftoside ameliorates oxygen glucose deprivation-induced inflammation associated with the TLR4/Myd88/Drp1-related mitochondrial fission in BV2 microglia cells
10.1016/j.jphs.2018.10.012 · ExternalCitation · doi-reference
Unveiling the antiurolithiatic potentiality of two benzene sulfonamide derivatives against ethylene glycol-induced renal calculi
10.1016/j.nefroe.2025.02.003 · ExternalCitation · doi-reference
Isoflavanones and their O-glycosides from Desmodium styracifolium
10.1016/j.phytochem.2007.02.015 · ExternalCitation · doi-reference
Pediatric urinary stone disease in the United States: the urologic diseases in America project
10.1016/j.urology.2019.04.012 · ExternalCitation · doi-reference
A comparative study of kidney lithogenic agents in Wistar rats by invasive and noninvasive methods
10.1016/j.vascn.2025.107743 · ExternalCitation · doi-reference
Schaftoside suppresses pentylenetetrazol-induced seizures in zebrafish via suppressing apoptosis, modulating inflammation, and oxidative stress
10.1021/acschemneuro.1c00314 · ExternalCitation · doi-reference
Styracifoline from the Vietnamese plant Desmodium styracifolium: a potential inhibitor of diabetes-related and thrombosis-based proteins
10.1021/acsomega.1c02840 · ExternalCitation · doi-reference
NIH Image to ImageJ: 25 years of image analysis
10.1038/nmeth.2089 · ExternalCitation · doi-reference
Kidney stone disease: risk factors, pathophysiology and management
10.1038/s41581-025-00990-x · ExternalCitation · doi-reference
Activation of Farnesoid X receptor by schaftoside ameliorates acetaminophen-induced hepatotoxicity by modulating oxidative stress and inflammation
10.1089/ars.2019.7791 · ExternalCitation · doi-reference
Effect of Desmodium styracifolium‐triterpenoid on calcium oxalate renal stones
10.1111/j.1464-410x.1993.tb15906.x · ExternalCitation · doi-reference
Puerarin alleviates apoptosis and inflammation in kidney stone cells via the PI3K/AKT pathway: network pharmacology and experimental verification
10.1111/jcmm.70180 · ExternalCitation · doi-reference
Principles and standards for reporting animal experiments in the journal of physiology and experimental physiology
10.1113/ep085299 · ExternalCitation · doi-reference
Urolithiasis unveiled: pathophysiology, stone dynamics, types, and inhibitory mechanisms: a review
10.1186/s12301-024-00436-z · ExternalCitation · doi-reference
Study on the constituents of Desmodium styracifolium
10.1248/cpb.37.2229 · ExternalCitation · doi-reference
Schaftoside improves cerebral ischemia-reperfusion injury by enhancing autophagy and reducing apoptosis and inflammation through the AMPK/mTOR pathway
10.17219/acem/152207 · ExternalCitation · doi-reference
In focus: perplexing increase of urinary stone disease in children, adolescent and young adult women and its economic impact
10.3389/fmed.2023.1272900 · ExternalCitation · doi-reference
Kidney stones: a global picture of prevalence, incidence, and associated risk factors
10.3909/riu0459 · ExternalCitation · doi-reference
Trends in kidney stone prevalence among U.S. adults: a concerning contemporary gender analysis from the NHANES database
10.5489/cuaj.8935 · ExternalCitation · doi-reference
